rs7420331
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000393.5(COL5A2):c.456+1674T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.133 in 152,026 control chromosomes in the GnomAD database, including 1,365 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.13 ( 1365 hom., cov: 30)
Consequence
COL5A2
NM_000393.5 intron
NM_000393.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.41
Publications
3 publications found
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.175 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A2 | NM_000393.5 | c.456+1674T>C | intron_variant | Intron 6 of 53 | ENST00000374866.9 | NP_000384.2 | ||
| COL5A2 | XM_011510573.4 | c.318+1674T>C | intron_variant | Intron 9 of 56 | XP_011508875.1 | |||
| COL5A2 | XM_047443251.1 | c.318+1674T>C | intron_variant | Intron 11 of 58 | XP_047299207.1 | |||
| COL5A2 | XM_047443252.1 | c.318+1674T>C | intron_variant | Intron 10 of 57 | XP_047299208.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL5A2 | ENST00000374866.9 | c.456+1674T>C | intron_variant | Intron 6 of 53 | 1 | NM_000393.5 | ENSP00000364000.3 | |||
| COL5A2 | ENST00000618828.1 | c.-175+1674T>C | intron_variant | Intron 6 of 46 | 5 | ENSP00000482184.1 | ||||
| COL5A2 | ENST00000649966.1 | c.318+1674T>C | intron_variant | Intron 6 of 10 | ENSP00000496785.1 | |||||
| ENSG00000228073 | ENST00000419029.1 | n.75-233A>G | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.133 AC: 20188AN: 151908Hom.: 1368 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
20188
AN:
151908
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.133 AC: 20181AN: 152026Hom.: 1365 Cov.: 30 AF XY: 0.134 AC XY: 9959AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
20181
AN:
152026
Hom.:
Cov.:
30
AF XY:
AC XY:
9959
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
4088
AN:
41460
American (AMR)
AF:
AC:
2019
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
787
AN:
3466
East Asian (EAS)
AF:
AC:
499
AN:
5176
South Asian (SAS)
AF:
AC:
890
AN:
4812
European-Finnish (FIN)
AF:
AC:
1453
AN:
10576
Middle Eastern (MID)
AF:
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9907
AN:
67954
Other (OTH)
AF:
AC:
326
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
882
1763
2645
3526
4408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
477
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.